Dynamic glucose-enhanced (DGE) MRI has shown potential for imaging glucose delivery and blood brain barrier permeability. Previous reports focused on the technical development of DGE and only a few clinical brain tumor cases have been reported. Here we incorporated the current DGE protocol into our routine MRI examination at 3T and performed a small-scale clinical observational study on patients with different types of brain tumors. Despite the technical challenges of DGE at clinical scanners, we observed different (non)-enhancement patterns with various brain tumor types.
This abstract and the presentation materials are available to members only; a login is required.